NeuroDawn Pharmaceutical — Series B
NeuroDawn Pharmaceutical raised $28.1M in a Series B round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- NeuroDawn Pharmaceutical
- Round Type
- Series B
- Amount Raised
- $28.1M
- Announced
- January 12, 2024
Canonical: https://fsome.com/funding/neurodawn-pharmaceutical-series-b-6162441 · For the full investor list, press references, and related rounds, please enable JavaScript.